Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

December 01, 1995; 45 (12) ARTICLES

Sydenham's chorea

Magnetic resonance imaging of the basal ganglia

J.N. Giedd, J.L. Rapoport, M.J.P. Kruesi, C. Parker, M.B. Schapiro, A.J. Allen, H.L. Leonard, D. Kaysen, D.P. Dickstein, W.L. Marsh, P.L. Kozuch, Vaituzis A.C., S.D. Hamburger, S.E. Swedo
First published December 1, 1995, DOI: https://doi.org/10.1212/WNL.45.12.2199
J.N. Giedd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.L. Rapoport
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.J.P. Kruesi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Parker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.B. Schapiro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.J. Allen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.L. Leonard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Kaysen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.P. Dickstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W.L. Marsh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.L. Kozuch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.D. Hamburger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S.E. Swedo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Sydenham's chorea
Magnetic resonance imaging of the basal ganglia
J.N. Giedd, J.L. Rapoport, M.J.P. Kruesi, C. Parker, M.B. Schapiro, A.J. Allen, H.L. Leonard, D. Kaysen, D.P. Dickstein, W.L. Marsh, P.L. Kozuch, Vaituzis A.C., S.D. Hamburger, S.E. Swedo
Neurology Dec 1995, 45 (12) 2199-2202; DOI: 10.1212/WNL.45.12.2199

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
172

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Analysis of cerebral magnetic resonance images of 24 subjects with Sydenham's chorea and 48 age-, height-, weight-, gender-, and handedness-matched controls demonstrated increased sizes of the caudate, putamen, and globus pallidus in the Sydenham's chorea group. In contrast, neither total cerebral, prefrontal, or midfrontal volumes or thalamic area were increased. These results indicate the selective involvement of the basal ganglia in Sydenham's chorea.

NEUROLOGY 1995;45: 2199-2203

Sydenham's chorea (SC) is characterized by sudden, involuntary, arrhythmic, aimless movements, often accompanied by muscular weakness and psychological symptoms including emotional lability, obsessive-compulsive disorder (OCD), anxiety, impulsivity, and inattentiveness. [1-3] SC is a semi-acute illness usually occurring during childhood or adolescence, following infection with group A betahemolytic streptococci (GABHS), and is a ``major'' criterion of rheumatic fever. [4] In rheumatic fever, antibodies directed against antigens on GABHS may cross-react with certain host tissues in the cardiac, skeletal, or central nervous systems. [5-7] CNS involvement, particularly of the basal ganglia (BG), is assumed to be responsible for the adventitious movements and the behavioral manifestations of SC. Husby et al, [8] using immunofluorescent staining, demonstrated specific cross-reactivity of IgG antibodies to neuronal cytoplasmic antigens of the caudate and subthalamic nuclei.

BG involvement in SC is supported by postmortem studies [9-11] and functional and structural brain imaging. [12-16] Case reports of brain imaging strongly suggest BG involvement in SC, but there has not been a reported multisubject quantitative brain imaging study of SC. In addition to providing information about BG dysfunction in SC, a more detailed analysis of BG structures is of interest because of the association of SC with OCD, a disorder possibly secondary to BG dysfunction. [17] We compare in vivo quantitative MRI morphology of BG structures in 24 pediatric subjects with acute SC with 48 age-, height-, weight-, handedness-, and gender-matched controls.

Methods.

Subjects.

Subjects with recent onset of chorea were referred by pediatricians and neurologists nationwide. Each potential subject was evaluated by a pediatric neurologist (C.P. and/or M.B.S.) and only cases of recentonset SC were accepted. [4] Because SC is frequently a diagnosis of exclusion, children were not accepted into the study if they had a personal or family history of hereditary causes of chorea, other neurologic abnormalities, or other infectious, immunologic, metabolic, or degenerative causes of chorea.

Eight boys and 16 girls, ages 7.1 to 16.3 years, were accepted into the study. Physical and psychological characteristics of these patients have been described previously. [3,18]

Assessment included a medical history, laboratory tests, and physical and neurologic examinations, [3] including ratings of chorea severity modified from Aron et al. [19] In addition, all subjects underwent the structured psychiatric interviews and neuropsychological tests as described below for the control group.

Controls.

Two control subjects, matched for age, gender, height, and handedness, were selected for each clinical subject (see Table 1 for comparison of subject and control characteristics). Controls were recruited from the local community. Individuals with medical, neurologic, or lifetime history of psychiatric abnormalities, or who had first-degree relatives with major psychiatric disorders, were excluded. Behavioral measures of subjects with SC and controls included the 12 handedness items from the Physical and Neurological Examination for Subtle Signs inventory [20] and clinical psychiatric interviews using the Child and Parent Diagnostic Interview for Children and Adolescents. [21]

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 1. Subject characteristics

The protocol was approved by the Institutional Review Board of the National Institute of Mental Health. Written assent from the child and consent from the parents were obtained.

MRI protocol.

All subjects were imaged on a GE 1.5-tesla Signa imager. T1-weighted images with section thickness of 1.5 mm in the axial and sagittal planes and 2.0 mm in the coronal plane were obtained using threedimensional spoiled gradient recalled echo in the steady state (3D SPGR). Imaging parameters were TE equals 5, TR equals 24, flip angle equals 45 degrees, acquisition matrix equals 192 times 256, NEX equals 1, and FOV equals 24 cm. Head position was standardized by assuring that three external markers (vitamin E capsules in the meatus of each ear and one taped to the left inferior orbital ridge) were all visible in the same axial reference plane. Foam padding was placed on both sides of the patient's head to minimize head movement. Subjects underwent imaging in the evening to promote their falling asleep in the imager. Younger children were allowed to bring blankets or stuffed animals into the imager and have their parents read to them. Sedation with chloral hydrate (1.5 to 2.0 g by mouth) was used for four of the SC subjects. Control subjects were not sedated.

Image analysis.

A clinical neuroradiologist reviewed all images. No abnormalities were noted in the control group. In the SC group, one subject (9-year-old boy) had a cleft defect in the right parietal lobe and another subject (16-year-old girl) had a focal area of T2 hyperintensity in the right caudate. These subjects were retained in the data set. Images were transferred to a Macintosh II FX computer workstation and analyzed with an image analysis program (NIH Image 1.52) developed at the NIH. [22]

The caudate nuclei and putamen were measured on all coronal sections on which they were visible. The globus pallidus (GP) was measured on coronal sections beginning 2 mm anterior to the anterior commissure and proceeding posteriorly for a total of 14 mm. Limiting sampling to this domain, which encompassed almost the entire GP in the majority of subjects, improved intrarater reliability. Distinctions between internal and external components of the GP were not reliably discernible with our methodology.

Volumetric quantification of the thalamus was not possible with our methods. To provide a limited measure of thalamus size the area from a single midsagittal section was used. The midsagittal section was reconstructed from the axial series, which allows more precise designation of the midsagittal plane than choosing a ``best'' midsagittal section from the sagittal series.

Total cerebral volume was determined from axial sections using a supervised thresholding technique that separates gray and white matter from CSF. The designation ``prefrontal'' was given to all brain matter anterior to the anterior-most point of the genu of the corpus callosum, excluding temporal lobe tissue. The designation ``midfrontal'' was given to all brain matter posterior to the plane at the tip of the genu and anterior to the anterior commissure. It should be noted that these boundaries are somewhat arbitrary and are not based on histologic or cytoarchitectonic characteristics.

Statistical analysis.

T tests were used to assess group differences in age, height, weight, and total brain volume. Chi square was used to assess handedness differences. Intraclass correlation coefficients were used to assess intrarater reliability of measurements. For a given structure the same rater performed all of the measurements blind to any subject characteristics. Repeatedmeasures ANOVA was used to assess group differences in structure size. Since there were no group differences in total brain volume, results are reported for the actual volumes, uncorrected for brain size. A univariate analysis was performed to assess normality of distribution of the data. Spearman's correlations were used to assess the relationships between those structures that differed between groups and measures of chorea severity, obsessive compulsive symptom severity, duration of symptoms, and exposure to neuroleptics.

Results.

Intraclass correlations of interrater reliability were as follows: caudate equals 0.88, putamen equals 0.84, GP equals 0.82, thalamus equals 0.85, total cerebral volume equals 0.99, prefrontal region equals 0.98, midfrontal region equals 0.98.

As indicated in Table 2, there were no differences in volume of the total hemispheres, prefrontal, or midfrontal regions, or thalamus area. In contrast, the caudate, putamen, and GP were all significantly larger in the SC group. The differences averaged 10% for the caudate and GP and 7% for the putamen.

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 2. Volume of basal ganglia, prefrontal, midfrontal, and total brain in Sydenham's chorea (N equals 24) and age-, sex-, height-, and weight-matched controls (N equals 48)

The Figure 1 shows scatterplots of the BG structures demonstrating large variance of structure size and considerable overlap between groups, but larger mean values for the caudate, putamen, and GP in the SC group. As seen, few patients' volumes exceeded the normal range, although about half of the normal subjects' measures were below the patient range. Symmetry measures of BG structures did not differ between the groups.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Scatterplots of basal ganglia volumes (ml) by diagnosis for 24 subjects with Sydenham's chorea and 48 age-, height-, weight-, and gender-matched controls.

In the SC group, there were no significant correlations between brain structure size and duration of symptoms prior to imaging, degree of obsessivecompulsive symptom severity, total dosage or duration of neuroleptic use prior to imaging, or severity of choreiform movements.

Discussion.

Dysfunction of any portion of the complex circuitry of the BG might account for the manifestations of SC. [23-26] In our study, the caudate, putamen, and GP all demonstrated volumetric differences. Since most neural circuitry models identify a direct pathway involving the internal component of the GP and an indirect pathway involving the external component of the GP and the subthalamic nucleus, [23] the inability of our methodology to discriminate between the internal and external components of the GP represents a noteworthy methodologic limitation.

The lack of difference in prefrontal volume, midfrontal volume, or thalamic area is consistent with earlier work indicating some specificity of the antigens to BG structures. [8] The lack of differences in the thalamus may reflect insensitivity of our technique (ie, measuring one midsagittal section of the entire thalamus to assess functionally discrete nuclei within it) or that the pathophysiology of SC does not affect the size of the thalamus.

A possible confounding factor is neuroleptic exposure, as this has been related to increased volume of BG in young schizophrenia patients. [27] In our sample, there were no correlations between BG sizes and total dosage or duration of neuroleptic exposure prior to imaging, although the interaction of a neuroleptic-mediated process with an inflammatory reaction may be difficult to discern. The large variability and considerable overlap in structure size between SC subjects and controls make volumetric MRI of limited diagnostic utility in this disorder, although MRI may be useful to rule out other focal disorders that cause chorea.

In summary, this is the first systematic quantitative MRI study of SC using a large sample to examine neuroanatomic differences in various BG structures. Significant and specific increases in size were present for the caudate, putamen, and GP. These results are consistent with a hypothesis of a cross-reactive antibody-mediated inflammation of the BG as being the pathophysiologic mechanism for this disorder.

  • Copyright 1995 by Advanstar Communications Inc.

REFERENCES

  1. 1.↵
    Stollerman GH. Rheumatic fever. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, eds. Harrison's principles of internal medicine. New York: McGraw Hill, 1991:935.
  2. 2.
    Ebaugh FG. Neuropsychiatric aspects of chorea in children. JAMA 1926;87:1083-1088.
    OpenUrlCrossRef
  3. 3.↵
    Swedo SE, Leonard HL, Schapiro MB, et al. Sydenham's chorea: physical and psychological symptoms of St. Vitus dance. Pediatrics 1993;91:706-713.
    OpenUrl
  4. 4.↵
    Special Writing group of the Committee of Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease of the Young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. JAMA 1992;268:2069-2073.
    OpenUrl
  5. 5.↵
    Taranta A, Stollerman GH. The relationship of Sydenham's chorea to infection with group A streptococci. Am J Med 1956;20:170-175.
    OpenUrlCrossRefPubMed
  6. 6.
    Goldenberg J, Ferraz MB, Fonseca ASM, Hilario MO, Bastos W, Sachetti S. Sydenham chorea: clinical and laboratory findings. Analysis of 187 cases. Rev Paul Med 1992;110:152-157.
    OpenUrl
  7. 7.
    Ayoub EM, Wannamaker LW. Streptococcal antibody titers in Sydenham's chorea. Pediatrics 1966;38:946-956.
    OpenUrl
  8. 8.↵
    Husby G, Van De Rijn I, Zabriskie JB, Abdin ZH, Williams RC. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 1976;144:1094-1110.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Ziegler LH. The neuropathological findings in a case of acute Sydenham's chorea. J Nerv Ment Dis 1927;65:273-281.
    OpenUrl
  10. 10.
    Greenfield JG, Wolfsohn JM. The pathology of Sydenham's chorea. Lancet 1922;32:603-606.
    OpenUrl
  11. 11.
    Kolb B, Whishaw IQ, Fundamentals of human neuropsychology. San Francisco: Freeman, 1980.
  12. 12.↵
    Goldman S, Amrom D, Szliwowski HB, et al. Reversible striatal hypermetabolism in a case of Sydenham's chorea. Mov Disord 1993;8:355-358.
    OpenUrl
  13. 13.
    Jergas M, Heye N, Pohlau D, Schaffstein J. Computertomographische Befunde bei Chorea minor (Sydenham) [Computed tomographic findings in chorea minor (Sydenham's chorea)]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1992;157:288-290.
    OpenUrl
  14. 14.
    Kienzle GD, Breger RK, Chun RWM, Zupanc ML, Sackett JF. Sydenham chorea: MR manifestations in two cases. AJNR Am J Neuroradiol 1991;12:73-76.
    OpenUrl
  15. 15.
    Konagaya M, Konagaya Y. MRI in hemiballism due to Sydenham's chorea [letter]. J Neurol Neurosurg Psychiatry 1992;55:238-239.
    OpenUrlAbstract/FREE Full Text
  16. 16.
    Heye N, Jergas M, Hotzinger H, Farahati J, Pohlau D, Przuntek H. Sydenham chorea: clinical, EEG, MRI and SPECT findings in the early stage of the disease. J Neurol 1993;240:121-123.
    OpenUrlCrossRefPubMed
  17. 17.↵
    Swedo SE, Rapoport JL, Cheslow DL, et al. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am J Psychiatry 1989;146:246-249.
    OpenUrlCrossRef
  18. 18.
    Swedo SE. Sydenham's chorea: a model for childhood autoimmune neuropsychiatric disorders. JAMA 1994;272:1788-1791.
    OpenUrl
  19. 19.↵
    Aron AM, Freeman JM, Carter S. The natural history of Sydenham's chorea. Am J Med 1965;38:83-95.
    OpenUrl
  20. 20.↵
    Denckla MB. Revised physical and neurological examination for subtle signs. Psychopharmacol Bull 1985;21:773-800.
    OpenUrlPubMed
  21. 21.↵
    Welner Z, Reich W, Herjanic B, Jung K, Amado H. Reliability, validity and child agreement studies of the diagnostic interview of children and adolescents (DICA). J Am Acad Child Adolesc Psychiatry 1987;26:649-653.
    OpenUrl
  22. 22.↵
    Rasband W. NIH Image (1.52). Bethesda, MD: National Institutes of Health (Public Domain), 1993.
  23. 23.↵
    Hallet M. Physiology of basal ganglia disorders: an overview. Can J Neurol Sci 1993;20:177-183.
    OpenUrl
  24. 24.
    Alexander GE, Crutcher MD, DeLong MR. Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, `prefrontal' and `limbic' functions. Prog Brain Res 1990;85:119-145.
    OpenUrlPubMed
  25. 25.
    Mink JW, Thach WT. Basal ganglia intrinsic circuits and their role in behavior. Curr Opin Neurobiol 1993;3:950-957.
    OpenUrl
  26. 26.
    Gerfen CR. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 1992;15:285-320.
    OpenUrlPubMed
  27. 27.↵
    Chakos MH, Lieberman JA, Bilder RM, et al. Caudate nuclei volumes increase in first episode schizophrenia with antipsychotic drug treatment. Am J Psychiatry 1994;151:1430-1436.
    OpenUrlPubMed

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 99 (7)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise